Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Merkel

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Annals of the Rheumatic Diseases|December 4, 2014
Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)A J Mohammad, A Hot, F Arndt, et al.
Arthritis and Rheumatism|February 14, 2012
Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosisP A Merkel, N P Silliman, P J Clements, et al.
Annals of the Rheumatic Diseases|September 26, 2007
Development of a provisional core set of response measures for clinical trials of systemic sclerosisD Khanna, D J Lovell, E Giannini, et al.
Annals of the Rheumatic Diseases|July 31, 2008
Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitisP A Merkel, D D Cuthbertson, B Hellmich, et al.
Annals of the Rheumatic Diseases|October 4, 2007
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task forceC Mukhtyar, O Flossmann, B Hellmich, et al.
Clinical and Experimental Rheumatology|August 4, 2009
Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosisJ D Finkielman, P A Merkel, D Schroeder, et al.
Clinical and Experimental Immunology|January 12, 2017
Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitisJ M Clain, A M Hummel, J H Stone, et al.
Annals of the Rheumatic Diseases|April 17, 2008
EULAR recommendations for the management of primary small and medium vessel vasculitisC Mukhtyar, L Guillevin, M C Cid, et al.
Annals of the Rheumatic Diseases|April 17, 2008
EULAR recommendations for the management of large vessel vasculitisC Mukhtyar, L Guillevin, M C Cid, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2015
Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoidsE M Miloslavsky, U Specks, P A Merkel, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Annals of the Rheumatic Diseases|December 4, 2014
Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)A J Mohammad, A Hot, F Arndt, et al.
Arthritis and Rheumatism|February 14, 2012
Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosisP A Merkel, N P Silliman, P J Clements, et al.
Annals of the Rheumatic Diseases|September 26, 2007
Development of a provisional core set of response measures for clinical trials of systemic sclerosisD Khanna, D J Lovell, E Giannini, et al.
Annals of the Rheumatic Diseases|July 31, 2008
Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitisP A Merkel, D D Cuthbertson, B Hellmich, et al.
Annals of the Rheumatic Diseases|October 4, 2007
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task forceC Mukhtyar, O Flossmann, B Hellmich, et al.
Clinical and Experimental Rheumatology|August 4, 2009
Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosisJ D Finkielman, P A Merkel, D Schroeder, et al.
Clinical and Experimental Immunology|January 12, 2017
Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitisJ M Clain, A M Hummel, J H Stone, et al.
Annals of the Rheumatic Diseases|April 17, 2008
EULAR recommendations for the management of primary small and medium vessel vasculitisC Mukhtyar, L Guillevin, M C Cid, et al.
Annals of the Rheumatic Diseases|April 17, 2008
EULAR recommendations for the management of large vessel vasculitisC Mukhtyar, L Guillevin, M C Cid, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2015
Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoidsE M Miloslavsky, U Specks, P A Merkel, et al.
Pageof 5